Kiora Pharmaceuticals (KPRX) Institutional Ownership $3.67 -0.07 (-1.87%) (As of 03:15 PM ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Kiora Pharmaceuticals (NASDAQ:KPRX)CurrentInstitutional OwnershipPercentage76.97%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$15.45MNumber ofInstitutional Sellers(last 12 months)3TotalInstitutional Outflows(last 12 months)$24.27M Get KPRX Insider Trade Alerts Want to know when executives and insiders are buying or selling Kiora Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data KPRX Institutional Buying and Selling by Quarter Ad WealthPressBreaking News: Tesla headed to $500…That headline hit late last night…and the rally has begun Which is why we want to urge you to go ahead and download Lance’s e-Book now outlining his bullish case for Tesla. So to claim your free digital copy today, simply follow this link and enter your email address. Kiora Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/21/2024Stonepine Capital Management LLC200,000$840K0.8%N/A6.856% 8/20/2024Nantahala Capital Management LLC211,110$887K0.1%-88.9%7.237% 8/7/2024AIGH Capital Management LLC255,561$1.07M0.3%-88.9%8.761% 7/12/2024 Rosalind Advisors Inc.255,555$1.07M0.8%-88.9%8.752% 4/25/2024 Rosalind Advisors Inc.2,300,000$1.62M1.5%N/A8.759% (Data available from 1/1/2016 forward) KPRX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of KPRX shares? During the previous two years, the following institutional investors and hedge funds held shares of Kiora Pharmaceuticals shares: AIGH Capital Management LLC ($1.07M), Rosalind Advisors Inc. ($1.07M), and Nantahala Capital Management LLC ($887K), Stonepine Capital Management LLC ($840K).Learn more on KPRX's institutional investors. What percentage of Kiora Pharmaceuticals stock is owned by institutional investors? 76.97% of Kiora Pharmaceuticals stock is owned by institutional investors. Learn more on KPRX's institutional investor holdings. Which institutional investors have been buying Kiora Pharmaceuticals stock? The following institutional investors have purchased Kiora Pharmaceuticals stock in the last 24 months: Rosalind Advisors Inc. ($2.30M), and Stonepine Capital Management LLC ($200K). How much institutional buying is happening at Kiora Pharmaceuticals? Institutional investors have bought a total of 2,500,000 shares in the last 24 months. This purchase volume represents approximately $15.45M in transactions. Which Kiora Pharmaceuticals major shareholders have been selling company stock? The following institutional investors have sold Kiora Pharmaceuticals stock in the last 24 months: Rosalind Advisors Inc. ($2.04M), AIGH Capital Management LLC ($2.04M), and Nantahala Capital Management LLC ($1.69M). How much institutional selling is happening at Kiora Pharmaceuticals? Institutional investors have sold a total of 5,777,774 shares in the last 24 months. This volume of shares sold represents approximately $24.27M in transactions. Related Companies ProPhase Labs Institutional Ownership Clene Institutional Ownership Passage Bio Institutional Ownership CalciMedica Institutional Ownership NextCure Institutional Ownership Lumos Pharma Institutional Ownership Lexaria Bioscience Institutional Ownership Lantern Pharma Institutional Ownership Surrozen Institutional Ownership BioLineRx Institutional Ownership This page (NASDAQ:KPRX) was last updated on 11/12/2024 by MarketBeat.com Staff From Our PartnersAmazon's $150B Data Center Bet—What It Means for Uranium InvestorsAmazon is placing a massive bet on nuclear energy to power its $150 billion data center expansion. With dem...The Bull Report | SponsoredOptions Trading on Bitcoin?SEC Approves Crypto Options Trading Select altcoins poised for RAPID growth by early 2025… Crypto 101 Media | SponsoredCentral Bank Abandons USDStartling new evidence shows the U.S. Central Bank is abandoning the currency we’ve relied on for centuries – ...True Gold Republic | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredElection warning coming true… If you missed it, my emergency election broadcast is now available - watch it before it's too late.Porter & Company | SponsoredCritical warning from the mountains of CarolinaNvidia CEO Jensen Huang says Big Tech will spend over $1 trillion on data centers. And that still might not...Weiss Ratings | SponsoredCrypto’s FINAL Wealth MomentBitcoin’s final bull market is here. If you missed out on the gains in 2017, or 2021… 2025 stands to be jus...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kiora Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kiora Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free KPRX Stock Alerts